After voters overwhelmingly approved Referendum 310 -- upholding Denver's ban on the sale of flavored tobacco and vaping ...
If you spend any time around cannabis enthusiasts in Michigan, you’ve probably heard of 710 Labs. The Colorado-born company has built a cult following for its terp-heavy live rosin, a solventless ...
Menthol in tobacco is a serious public health problem. According to the Centers for Disease Control and Prevention, menthol ...
CLARKSVILLE -- Exhibitors across Iowa will be selling handmade and repurposed creations at the 21st Annual Craft Expo.
Sacramento Kings coach Doug Christie spelled out his game plan prior to Wednesday’s season opener against the Phoenix Suns. “We defend, we rebound and we share,” Christie said. “That’s the overarching ...
Hosted on MSN
Is Bryant Gumbel a smoker? Cancer diagnosis and more on former Today host’s health issues amid hospitalization
According to reports, veteran television journalist Bryant Gumbel has been hospitalized due to a medical emergency in New York City. TMZ claims that the 77-year-old former Today show host was taken ...
Please provide your email address to receive an email when new articles are posted on . Data from a single primary care clinic showed a higher proportion of smokers were eligible to receive a GLP-1 ...
In 2009, Congress enacted legislation authorizing the U.S. Federal Food and Drug Administration to comprehensively regulate tobacco and nicotine products. Included in that legislation was the ...
Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. The Supreme Court will consider whether people who ...
WASHINGTON — The Supreme Court said on Monday that it will consider whether people who regularly smoke marijuana can legally own guns, the latest firearm case to come before the court since its 2022 ...
WASHINGTON — The Supreme Court said on Monday that it will consider whether people who regularly smoke marijuana can legally own guns, the latest firearm case to come before the court since its 2022 ...
Gilead Sciences' Kite Pharma is doubling down on in vivo CAR-T, this time inking a deal worth up to $1.64 billion biobucks with Chinese biotech Pregene Biopharma. Kite has paid out $120 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results